» Articles » PMID: 35345785

Magnetic Nano-Platform Enhanced IPSC-Derived Trabecular Meshwork Delivery and Tracking Efficiency

Overview
Publisher Dove Medical Press
Specialty Biotechnology
Date 2022 Mar 29
PMID 35345785
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Transplantation of stem cells to remodel the trabecular meshwork (TM) has become a new option for restoring aqueous humor dynamics and intraocular pressure homeostasis in glaucoma. In this study, we aimed to design a nanoparticle to label induced pluripotent stem cell (iPSC)-derived TM and improve the delivery accuracy and in vivo tracking efficiency.

Methods: PLGA-SPIO-Cypate (PSC) NPs were designed with polylactic acid-glycolic acid (PLGA) polymers as the backbone, superparamagnetic iron oxide (SPIO) nanoparticles, and near-infrared (NIR) dye cypate. In vitro assessment of cytotoxicity, iron content after NPs labeling, and the dual-model monitor was performed on mouse iPSC-derived TM (miPSC-TM) cells, as well as immortalized and primary human TM cells. Cell function after labeling, the delivery accuracy, in vivo tracking efficiency, and its effect on lowering IOP were evaluated following miPSC-TM transplantation in mice.

Results: Initial in vitro experiments showed that a single-time nanoparticles incubation was sufficient to label iPSC-derived TM and was not related to any change in both cell viability and fate. Subsequent in vivo evaluation revealed that the use of this nanoparticle not only improves the delivery accuracy of the transplanted cells in live animals but also benefits the dual-model tracking in the long term. More importantly, the use of the magnet triggers a temporary enhancement in the effectiveness of cell-based therapy in alleviating the pathologies associated with glaucoma.

Conclusion: This study provided a promising approach for enhancing both the delivery and in vivo tracking efficiency of the transplanted cells, which facilitates the clinical translation of stem cell-based therapy for glaucoma.

Citing Articles

iPSC-derived cells stimulate ABCG2/NES endogenous trabecular meshwork cell proliferation and tissue regeneration.

Xi G, Feng P, Zhang X, Wu S, Zhang J, Wang X Cell Prolif. 2024; 57(7):e13611.

PMID: 38356373 PMC: 11216930. DOI: 10.1111/cpr.13611.


Nanotechnology in Retinal Disease: Current Concepts and Future Directions.

Mehta N, Mehta S J Ocul Pharmacol Ther. 2023; 40(1):3-12.

PMID: 38052063 PMC: 10890960. DOI: 10.1089/jop.2023.0083.


iPSCs-Based Therapy for Trabecular Meshwork.

Zhu W, Zhang X, Wu S, Wang N, Kuehn M Handb Exp Pharmacol. 2023; 281:277-300.

PMID: 37495850 DOI: 10.1007/164_2023_671.


Improved magnetic delivery of cells to the trabecular meshwork in mice.

Fard M, Chan J, Sanchez Rodriguez G, Yonk M, Kuturu S, Read A Exp Eye Res. 2023; 234:109602.

PMID: 37488007 PMC: 10530071. DOI: 10.1016/j.exer.2023.109602.


A bibliometric analysis of the application of stem cells in glaucoma research from 1999 to 2022.

Tao Y, Zhang Q, Meng M, Huang J Front Cell Dev Biol. 2023; 11:1081898.

PMID: 36743419 PMC: 9889543. DOI: 10.3389/fcell.2023.1081898.

References
1.
Veiseh O, Gunn J, Zhang M . Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging. Adv Drug Deliv Rev. 2009; 62(3):284-304. PMC: 2827645. DOI: 10.1016/j.addr.2009.11.002. View

2.
Momeni A, Neelamegham S, Parashurama N . Current challenges for the targeted delivery and molecular imaging of stem cells in animal models. Bioengineered. 2016; 8(4):316-324. PMC: 5553333. DOI: 10.1080/21655979.2016.1233090. View

3.
Yu Z, Li Q, Wang J, Yu Y, Wang Y, Zhou Q . Reactive Oxygen Species-Related Nanoparticle Toxicity in the Biomedical Field. Nanoscale Res Lett. 2020; 15(1):115. PMC: 7239959. DOI: 10.1186/s11671-020-03344-7. View

4.
Zhang L, Xue H, Gao C, Carr L, Wang J, Chu B . Imaging and cell targeting characteristics of magnetic nanoparticles modified by a functionalizable zwitterionic polymer with adhesive 3,4-dihydroxyphenyl-l-alanine linkages. Biomaterials. 2010; 31(25):6582-8. DOI: 10.1016/j.biomaterials.2010.05.018. View

5.
Petters C, Irrsack E, Koch M, Dringen R . Uptake and metabolism of iron oxide nanoparticles in brain cells. Neurochem Res. 2014; 39(9):1648-60. DOI: 10.1007/s11064-014-1380-5. View